MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Wyeth today announced that the company ranked 11th in the fifth annual Top 20 Biotech and Pharmaceutical Employers Survey by Science magazine. Last year, the Company ranked 19th. The annual listing appeared in the magazine’s October 20, 2006 issue.
“The caliber and talent of Wyeth employees are what make our company a success, and we are always looking for ways to foster and encourage them to sustain and build our business. To have Science acknowledge our efforts for the second year in a row is a privilege,” says Robert R. Ruffolo, Jr., Ph.D., President, Wyeth Research, Senior Vice President, Wyeth.
With research and development programs focused on small molecules, vaccines and biotechnology, Wyeth is exploring more than 70 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer’s disease and schizophrenia.
Science readers and subscribers, and individuals identified as working in biotechnology and pharmaceutical industries, were invited to participate in the Web-based survey, which took place from May 2 to June 4, 2006. Respondents rated companies on attributes from categories including corporate image, leadership and direction, financial prowess, work culture/environment, work/life balance, academics and collegial exchange, and compensation and benefits. For more information, visit http://www.sciencemag.org.
About Wyeth
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Wyeth
CONTACT: Gerald Burr of Wyeth Pharmaceuticals, +1-484-865-5138, or JustinVictoria, Investor Contact, +1-973-660-5340, or Douglas Petkus,+1-973-660-5218, both of Wyeth
